Please enter mandatory and valid details

Revolutionizing Digital Pathology
with Precision and Innovation

Nuclear-biomarker-analysis

At OptraSCAN, we are committed to transforming digital pathology with our state-of-the-art nuclear biomarker analytics. Our comprehensive solutions harness the power of AI and machine learning to deliver accurate, detailed, and clinically relevant insights, fundamentally changing how pathologists and researchers analyze and interpret tissue specimens. With our advanced technology, we provide tools that not only enhance diagnostic precision but also streamline workflows, making pathology more efficient and accessible.

Key Features of Our Nuclear Algorithm

Computer-Assisted Assessment:

  • Advanced Machine Learning Technology: Our cutting-edge machine learning algorithms provide precise quantification of nuclear biomarker expression across whole-slide images and specific regions of interest. This capability ensures that pathologists can rely on accurate, reproducible data for informed decision-making.

Identification Vectors:

  • Precise Vector Identification: Our system accurately identifies nuclear (hematoxylin) and positive optical density vectors, enhancing the accuracy of your analyses. This precision allows for more detailed and meaningful insights into tissue samples.

Nuclear Segmentation:

  • Precision Segmentation: Our technology excels in separating overlapping nuclei, applying comprehensive filtering based on shape, size, roundness, compactness, and elongation. This detailed segmentation is crucial for accurate diagnosis and research.
  • Advanced Filtering: By utilizing sophisticated algorithms, we ensure that only the most relevant and accurate data is used, reducing noise and improving clarity.

User-Tunable Parameters:

  • Customizable Analysis: Users have the flexibility to train and adjust analysis parameters, including nuclei based on cell size, area, and staining intensity. This customization ensures that the results are tailored to specific needs and research goals.
  • Adaptable to Various Needs: Whether for research or clinical diagnostics, the ability to fine-tune parameters allows for a wide range of applications, from detailed research studies to routine clinical tests.

Clinically Relevant Data:

  • Pertinent Data Generation: Our system generates and quantifies data that is directly relevant to each clinical case, enhancing the diagnostic value of your findings. This relevance is critical for making accurate clinical decisions.
  • Improved Diagnostic Relevance: By focusing on clinically pertinent data, we help pathologists provide better-informed diagnoses, improving patient care and treatment outcomes.

Automation:

  • Complete Walk-Away Automation: Our technology supports single-slide analysis and batch processing with full walk-away automation, streamlining workflows and increasing productivity. This automation allows pathologists to focus on more complex cases and spend less time on routine tasks.
  • Efficiency and Productivity: Automation reduces the time required for analysis, enabling faster turnaround times and higher throughput, which is particularly beneficial in high-volume labs.

Why Choose OptraSCAN?

OptraSCAN's nuclear biomarker analytics offerings stand out for their precision, reliability, and user-friendly design. By integrating advanced AI technologies, we provide tools that enhance diagnostic accuracy and streamline workflows, making it easier for pathologists and researchers to deliver high-quality results.